Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1270Terminated 456Recruiting 294Unknown 246Active not recruiting 215Withdrawn 97Not yet recruiting 56Suspended 17Enrolling by invitation 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 7Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Neoplasms 40Breast Neoplasms 38Prostatic Neoplasms 24Colorectal Neoplasms 23Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 13Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 9Brain Neoplasms 9Lung Neoplasms 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Esophageal Neoplasms 7Sarcoma 6Ovarian Neoplasms 6Esophageal Squamous Cell Carcinoma 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Epilepsy 5Dementia 5Cholangiocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4

Interventions

cemiplimab 1Ruthenium-106 1Radiotherapy 1Melphalan 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Melanoma × Clear all
NCT06848088 2026-01-12

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Regeneron Pharmaceuticals

Phase 2 Enrolling by invitation
48 enrolled
Dermatologic

Melanoma

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation
10 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡